Sign in

CIK 0001070494

  • Large accelerated filer

ACADIA PHARMACEUTICALS INC

Sign in to watch
Ticker
ACAD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
061376651
Phone
+1 858-558-2871
Business address
12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Option exercise Director acquired 14,127 shares (option exercise)
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market sale Director sold 19,847 shares at $35.05 ($695,544)
  12. 4 Open-market sale CEO sold 30,000 shares at $34.30 ($1,028,868)
  13. 4 Open-market sale Director sold 10,000 shares at $33.63 ($336,349)
  14. 4 Open-market sale Director sold 27,973 shares at $33.02 ($923,766)
  15. 4 Open-market sale CEO sold 30,000 shares at $33.98 ($1,019,430)
  16. 4 Open-market sale Director sold 11,905 shares at $35.00 ($416,676)
  17. 4 Open-market sale Director sold 4,250 shares at $35.00 ($148,750)
  18. 4 Open-market sale Director sold 12,250 shares at $31.74 ($388,815)
  19. 4 Open-market sale CEO sold 30,000 shares at $31.00 ($929,916)
  20. 4 Option exercise EVP AND GC acquired 8,000 shares (option exercise)

Page 20 of 35 · 686 filings